AGA Medical Corporation Commends Updated U.K. Clinical Guidelines on Left Atrial Appendage Closure

MINNEAPOLIS--(BUSINESS WIRE)--AGA Medical Holdings, Inc. (AGA Medical) (Nasdaq: AGAM) commends the U.K.’s National Institute for Health and Clinical Excellence (NICE) for its newly issued guidelines. NICE concluded the percutaneous occlusion or closure of the left atrial appendage (LAA) reduces the risk of thromboembolic stroke associated with non-valvular atrial fibrillation (AF). The independent organization is responsible for providing national guidance on promoting good health and preventing and treating ill health.